Program: Microbiology
Defense Year: 1998
Advisor: Dan Mueller
Dissertation Title: "The Functional Consequences of T Cell Tolerance Induction In Vivo."

Program: MICaB
Defense Year: 2016
Advisor: Dan Mueller
Dissertation Title: "The Role of Anergy in Peripheral Tolerance."

Program: MICaB
Defense Year: 2003
Advisor: Dan Mueller
Dissertation Title: "Regulation of Primary CD4 T Cell Cycle Progression."

Program: MICaB
Defense Year: 2003
Advisor: Matthew Mescher
Dissertation Title: "The Roles of Interleukin-12 as a Third Signal for Clonal Expansion and Cytolytic Function of Naive CD8 T Cells."

Current Position: Clinical Research Associate, Houston, Texas

Program: MICaB
Defense Year: 2000
Advisor: Matthew Mescher
Dissertation Title: "Interleukin-12 as an Adjuvant and Activation Signal for CD8 Positive T Lymphocytes in Vivo."

Program: BMBB
Defense Year: 2002
Advisor: Matthew Mescher
Dissertation Title: "The Biochemical Basis for Activation-Induced Non-Responsiveness in CD8 T Cells."

Program: MICaB
Defense Year: 2007
Advisor: Matthew Mescher
Dissertation Title: "Targeting CD8 T Lymphocyte Activation for Tumor Immunotherapy Using Peptide Antigens and Cytokines."

Current Position: Research Associate,Department of Genetics, Cell Biology and Development (David Laraespada lab), University of Minnesota, Minneapolis, MN
Contact Info: [email protected]  

Program: Pathobiology
Defense Year: 1997
Advisor: Matthew Mescher
Dissertation Title: "Analysis of Primary and Memory CD8 Cytotoxic T Lymphocyte Responses inVivo: Tracking an Antigen Specific Response."

Current Position: Professor at University of Colorado Denver School of Medicine, Denver CO
Contact Info: [email protected]

Program: MCDB&G
Defense Year: 1997
Advisor: Matthew Mescher
Dissertation Title: "Regulation of the CD8 Receptor on Murine Cytotoxic T Lymphocytes."

Program: Molecular Pharmacology & Therapeutics
Defense Year: 2021
Advisor: Tanya Freedman
Dissertation Title: "Regulation of the kinases LYNA and LYNB and functions in autoimmune disease."